Table 3.
WF SS-OCTA characteristics | Number (percent, %)/Median(interquartile range,IQR) |
---|---|
Total number of NVs | 1 (1–3) |
Number of NVs located within the arcades | 1 (0–2) |
The number of NVs Located in mid periphery, and within the panoramic of Montage 15mm×15mm | 0 (0–2) |
NVE, yes (%) | 43 (78.2%) |
NVD, yes (%) | 23 (41.8%) |
Extensive NV, yes (%) | 8 (14.6%) |
EVP, yes (%) | 34 (61.8%) |
Number of NV with EVP | 1 (0–3) |
Flat NV, yes (%) | 25 (45.5%) |
Number of flat NVs | 0(0–1) |
Forward NV, yes (%) | 29 (52.7%) |
Number of forward NVs | 1 (0–1) |
Tabletop NV, yes (%) | 16 (29.1%) |
Number of tabletop NVs | 0 (0–1) |
Selected area of all NVs (mm2), per eye | 0.7 (0.2–4.2) |
Vessel density of all NVs, per eye | 0.5 (0.4–0.7) |
Skeletonized vessel density of all NVs, per eye | 0.2 (0.1–0.2) |
Flow area of NVs (selected area of all NVs × vessel density of NVs), per eye | 0.3 (0.1–1.9) |
Flow area of NVs (selected area of all NVs× skeletonized vessel density of NVs) (mm2)#, per eye | 0.1 (0.0–0.5) |
Ischemia index* | 0.1 (0.1–0.3) |
PVD, yes (%) | 34 (61.8%) |
Retina edema around NVE, yes (%) | 14 (25.5%) |
ERM, yes (%) | 33 (60.0%) |
NV=neovascularization; NVE=neovascularization elsewhere; NVD=neovascularization elsewhere;EVP=exuberant vascular proliferation; PVD=posterior vitreous detachment; ERM=epiretinal membrane;
Ischemia index=non-perfusion areas/total area.